- Global Pharma News & Resources

Glycated Albumin Assay Market Size to grow at a CAGR of 7.7% by 2027 | Global Industry Growth, Technology Advancement, Global Demand, Regional Statistics

Global Glycated Albumin Assay Market

Glycation is the process of bonding of a sugar molecule. For instance, glucose to a protein or a lipid molecule such as albumin. Glycated albumin is glucose bonded to an albumin molecule. Protein molecule i.e. albumin is present in blood, major body organs, and in body fluids. Function of albumin is to maintain shape of the cell, distribution of hormones, and nutrients. The amount of albumin decreases in the body when blood glucose levels are low and the amount of albumin increases in the body when blood glucose levels are high. Glycated albumin is measured during initiation of diabetes therapies to determine medication dose for treatment of diabetes.

Request for the trending sample of this report:

According to a study conducted by the American Association for Clinical Study, in 2011, glycated albumin have been described as novel biomarkers for the detection and management of diabetes. Treatment of diabetes require glycemic control. There are various measurements used to provide indicators, which includes glycated hemoglobin (HbA1c), 1, 5-anhydroglucitol (1,5AG) and glycated albumin.

Glycated hemoglobin (HbA1c) indicates the glycemic level during the first three months of diabetes. This measurement is useful for the confirmation of short term therapeutic efficacy during initiation of the treatment for diabetes. Glycated albumin assay is more useful for pregnant women suffering from diabetes.

Global Glycated Albumin Assay Market Dynamics

Approval of new products for detection of diabetes is expected to drive the global glycated albumin assay market growth. For instance, in 2011, Diazyme Laboratories, Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay Kit was approved by the U.S. Food and Drug Administration (FDA). Enzymatic glycated serum protein (GSP, Glycated Albumin) Assay is two part liquid stable reagent, which can be used with various types of automated clinical chemistry analyzers. This product provides additional diagnostic values to clinical practices in diabetes management and screening. Thus, approval of products to manage diabetes in a rapid and accurate way is expected to drive glycated albumin assay market growth.

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @

High prevalence of diabetes is expected to drive glycated albumin assay market growth. According to a survey conducted by National Institute of health (NIH), in 2016, more than 62 million people are diagnosed with diabetes in India.

However, the availability of alternative diabetes diagnosis method such as glucometer is expected to restrain the market growth. Furthermore, the vulnerability of variations offered by the test is also expected to decrease the adoption of glycated albumin assay, which in turn is restraining market growth.

Global Glycated Albumin Assay Market Regional Analysis:-

North America is expected to dominate the global glycated albumin assay market due to high prevalence of diabetes. According to a survey conducted by Center for disease control and prevention (CDC), in 2016, more than 30.3 million people in the U.S. are diagnosed with diabetes that accounts for around 9% of the U.S. population. More than 84.1 million people in U.S. are diagnosed with prediabetes. Such high prevalence of diabetes in U.S. is expected to boost growth of global glycated albumin assay market.

The Asia Pacific glycated albumin assay market is expected to witness significant growth due to FDA approvals of products launched by key players in this market. For instance, in 2017, Asahi Kasei Pharma Corporation, manufacturer of pharmaceuticals and pharmaceutical intermediates, received an approval for their new product, Lucica glycated albumin –L. It is an in vitro diagnostic assay kits. Asahi Kasei Pharma Corporation leveraged its own original enzymes to develop glycated albumin assay kits for use with biochemical auto analyzer. Approval of new product to manage diabetes is expected to drive glycated albumin assay market growth.

To understand Research Methodology, please click

Global Glycated Albumin Assay Market Key Players:-

The key players operating in global glycated albumin assay market include Epinex Diagnostics Inc., Simes Sikma biotechnology Co. Ltd., Ningbo Purebio biotechnology Co. Ltd., Asahi Kasei Pharma Corpoation, Life Span Diabetes Clinic, Exocell Inc., Diazyme Laboratories, Maccura Biotechnology Co. Ltd., and Abnova Corporation. These companies sell variety of products for diabetes monitoring. For instance, Epinex Diagnostics Inc.’s product includes Epinex G1A test. Epinex G1A test is a rapid diabetes monitoring index test, it is a monthly test to control the glycation. It allows earlier therapeutic intervention and also stores patient test results.

Key Developments

  • In June 2019, Abbott Laboratories launched Afinion HbA1c DX assay, one of the rapid point of care test for the diagnosis of diabetes condition.
  • In 2018, EKF Diagnostics Holdings Plc entered into distribution agreement with Asahi Kasei Pharma Corp. to market Asahi Kasei’s Lucica Glycated Albumin-L (Lucica GA) liquid reagent kits for the measurement of glycated albumin in the U.S.

View Press Release For More Information @

Market Taxonomy

By Product Type:

  • Glycated Albumin (human)
  • Glycated Albumin (animals)

By Application:

  • Diagnosis
    • Prediabetes
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Research

By End User:

  • Hospitals/Clinics
  • Diagnostic Centers
  • Research Institutes
  • Others

By Regions:

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East
  • Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Feb-2021